These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 21725594
41. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects. Wang Z, Dong H, Fu Y, Ding H. Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943 [Abstract] [Full Text] [Related]
42. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524 [Abstract] [Full Text] [Related]
43. Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families. Rapakko K, Heikkinen K, Karppinen SM, Winqvist R. Cancer Lett; 2006 May 08; 236(1):142-7. PubMed ID: 16005565 [Abstract] [Full Text] [Related]
44. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China. Wu Z, Wang P, Song C, Wang K, Yan R, Li J, Dai L. Mol Genet Genomics; 2015 Jun 08; 290(3):1141-53. PubMed ID: 25566853 [Abstract] [Full Text] [Related]
48. Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women. Romanowicz-Makowska H, Smolarz B, Połać I, Sporny S. J Obstet Gynaecol Res; 2012 Jun 08; 38(6):918-24. PubMed ID: 22487057 [Abstract] [Full Text] [Related]
49. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J. Cancer Res; 2003 Dec 15; 63(24):8717-25. PubMed ID: 14695186 [Abstract] [Full Text] [Related]
52. Identification of Rad51 alteration in patients with bilateral breast cancer. Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka H, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nagawa H, Nakamura Y, Miki Y. J Hum Genet; 2000 Dec 15; 45(3):133-7. PubMed ID: 10807537 [Abstract] [Full Text] [Related]
53. Polymorphisms of DNA repair genes and risk of glioma. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, Pudavalli V, Levin VA, Yung WK, Wei Q. Cancer Res; 2004 Aug 15; 64(16):5560-3. PubMed ID: 15313891 [Abstract] [Full Text] [Related]
54. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, Olszewski J, Morawiec-Sztandera A, Jendrzejczyk S, Mlynarski W, Majsterek I. Exp Mol Pathol; 2010 Dec 15; 89(3):358-66. PubMed ID: 20804747 [Abstract] [Full Text] [Related]
58. The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S. Eur J Gynaecol Oncol; 2012 Dec 15; 33(2):145-50. PubMed ID: 22611952 [Abstract] [Full Text] [Related]
59. Contribution of DNA double-strand break repair gene XRCC3 genotypes to oral cancer susceptibility in Taiwan. Tsai CW, Chang WS, Liu JC, Tsai MH, Lin CC, Bau DT. Anticancer Res; 2014 Jun 15; 34(6):2951-6. PubMed ID: 24922659 [Abstract] [Full Text] [Related]
60. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival. Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist K, Henriksson R, Butkiewicz D, Pamula-Pilat J, Tecza K, Hemminki K, Lenner P, Försti A. Breast Cancer Res Treat; 2011 Aug 15; 129(1):235-45. PubMed ID: 21455670 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]